aluates Reports

$ 0.0

Automative

Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2026

Published Date: 2026-02-09

Report Code: QYRE-Auto-34P18051

Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2024

BUY CHAPTERS

Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2026

Code: QYRE-Auto-34P18051

Report

2026-02-09

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Recipharm (Vibalogics)

Idt Biologika

FUJIFILM Diosynth Biotechnologies

Exothera

Lonza

Creative-Biolabs

Takara Bio

Libentech

ABL, Inc.

Nabios

HALIX

OBiO Technology

Porton Advanced

WuXi ATU

Genevoyager

Oncolytic Virus Manufacturing and Development Services Market

The global Oncolytic Virus Manufacturing and Development Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Oncolytic Virus Manufacturing and Development Services encompass the specialized processes involved in creating and optimizing viruses that selectively infect and destroy cancer cells. These services include the development of viral vectors, process optimization, large-scale production, purification, and quality control of oncolytic viruses. Additionally, they involve regulatory support, preclinical testing, and clinical trial manufacturing. The goal is to ensure that these viruses are produced safely and effectively for use in therapeutic applications, including cancer immunotherapy and combination treatments with other modalities.

The North American market for Oncolytic Virus Manufacturing and Development Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Oncolytic Virus Manufacturing and Development Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Oncolytic Virus Manufacturing and Development Services in R&D is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Oncolytic Virus Manufacturing and Development Services include Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Oncolytic Virus Manufacturing and Development Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncolytic Virus Manufacturing and Development Services. The Oncolytic Virus Manufacturing and Development Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oncolytic Virus Manufacturing and Development Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oncolytic Virus Manufacturing and Development Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oncolytic Virus Manufacturing and Development Services Market Report

Report Metric	Details
Report Name	Oncolytic Virus Manufacturing and Development Services Market
Segment by Type	Oncolytic Herpes Simplex Virus Oncolytic Adenovirus Oncolytic Vaccinia Virus Others
Segment by Application	R&D Biopharmaceutical Manufacturers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, Halix, Obio Technology, Porton Advanced, WuXi ATU, Genevoyager
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oncolytic Virus Manufacturing and Development Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Oncolytic Virus Manufacturing and Development Services Market report?

Ans: The main players in the Oncolytic Virus Manufacturing and Development Services Market are Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, Halix, Obio Technology, Porton Advanced, WuXi ATU, Genevoyager

What are the Application segmentation covered in the Oncolytic Virus Manufacturing and Development Services Market report?

Ans: The Applications covered in the Oncolytic Virus Manufacturing and Development Services Market report are R&D, Biopharmaceutical Manufacturers, Others

What are the Type segmentation covered in the Oncolytic Virus Manufacturing and Development Services Market report?

Ans: The Types covered in the Oncolytic Virus Manufacturing and Development Services Market report are Oncolytic Herpes Simplex Virus, Oncolytic Adenovirus, Oncolytic Vaccinia Virus, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oncolytic Herpes Simplex Virus

1.2.3 Oncolytic Adenovirus

1.2.4 Oncolytic Vaccinia Virus

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oncolytic Virus Manufacturing and Development Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 R&D

1.3.3 Biopharmaceutical Manufacturers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Manufacturing and Development Services Market Perspective (2021–2032)

2.2 Global Oncolytic Virus Manufacturing and Development Services Growth Trends by Region

2.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Oncolytic Virus Manufacturing and Development Services Historic Market Size by Region (2021–2026)

2.2.3 Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (2027–2032)

2.3 Oncolytic Virus Manufacturing and Development Services Market Dynamics

2.3.1 Oncolytic Virus Manufacturing and Development Services Industry Trends

2.3.2 Oncolytic Virus Manufacturing and Development Services Market Drivers

2.3.3 Oncolytic Virus Manufacturing and Development Services Market Challenges

2.3.4 Oncolytic Virus Manufacturing and Development Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue

3.1.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue (2021–2026)

3.1.2 Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Oncolytic Virus Manufacturing and Development Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Oncolytic Virus Manufacturing and Development Services Revenue

3.4 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio

3.4.1 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Manufacturing and Development Services Revenue in 2025

3.5 Global Key Players of Oncolytic Virus Manufacturing and Development Services Head Offices and Areas Served

3.6 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications

3.7 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Type

4.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Type (2021–2026)

4.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (2027–2032)

5 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Application

5.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Application (2021–2026)

5.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)

6.2 North America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)

6.4 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)

7.2 Europe Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)

7.4 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)

8.2 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)

9.2 Latin America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)

9.4 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)

10.2 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recipharm (Vibalogics)

11.1.1 Recipharm (Vibalogics) Company Details

11.1.2 Recipharm (Vibalogics) Business Overview

11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Introduction

11.1.4 Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.1.5 Recipharm (Vibalogics) Recent Development

11.2 IDT Biologika

11.2.1 IDT Biologika Company Details

11.2.2 IDT Biologika Business Overview

11.2.3 IDT Biologika Oncolytic Virus Manufacturing and Development Services Introduction

11.2.4 IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.2.5 IDT Biologika Recent Development

11.3 FUJIFILM Diosynth Biotechnologies

11.3.1 FUJIFILM Diosynth Biotechnologies Company Details

11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Introduction

11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.4 Exothera

11.4.1 Exothera Company Details

11.4.2 Exothera Business Overview

11.4.3 Exothera Oncolytic Virus Manufacturing and Development Services Introduction

11.4.4 Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.4.5 Exothera Recent Development

11.5 Lonza

11.5.1 Lonza Company Details

11.5.2 Lonza Business Overview

11.5.3 Lonza Oncolytic Virus Manufacturing and Development Services Introduction

11.5.4 Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.5.5 Lonza Recent Development

11.6 Creative Biolabs

11.6.1 Creative Biolabs Company Details

11.6.2 Creative Biolabs Business Overview

11.6.3 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Introduction

11.6.4 Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.6.5 Creative Biolabs Recent Development

11.7 Takara Bio

11.7.1 Takara Bio Company Details

11.7.2 Takara Bio Business Overview

11.7.3 Takara Bio Oncolytic Virus Manufacturing and Development Services Introduction

11.7.4 Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.7.5 Takara Bio Recent Development

11.8 Libentech

11.8.1 Libentech Company Details

11.8.2 Libentech Business Overview

11.8.3 Libentech Oncolytic Virus Manufacturing and Development Services Introduction

11.8.4 Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.8.5 Libentech Recent Development

11.9 ABL

11.9.1 ABL Company Details

11.9.2 ABL Business Overview

11.9.3 ABL Oncolytic Virus Manufacturing and Development Services Introduction

11.9.4 ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.9.5 ABL Recent Development

11.10 Nabios

11.10.1 Nabios Company Details

11.10.2 Nabios Business Overview

11.10.3 Nabios Oncolytic Virus Manufacturing and Development Services Introduction

11.10.4 Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.10.5 Nabios Recent Development

11.11 Halix

11.11.1 Halix Company Details

11.11.2 Halix Business Overview

11.11.3 Halix Oncolytic Virus Manufacturing and Development Services Introduction

11.11.4 Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.11.5 Halix Recent Development

11.12 Obio Technology

11.12.1 Obio Technology Company Details

11.12.2 Obio Technology Business Overview

11.12.3 Obio Technology Oncolytic Virus Manufacturing and Development Services Introduction

11.12.4 Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.12.5 Obio Technology Recent Development

11.13 Porton Advanced

11.13.1 Porton Advanced Company Details

11.13.2 Porton Advanced Business Overview

11.13.3 Porton Advanced Oncolytic Virus Manufacturing and Development Services Introduction

11.13.4 Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.13.5 Porton Advanced Recent Development

11.14 WuXi ATU

11.14.1 WuXi ATU Company Details

11.14.2 WuXi ATU Business Overview

11.14.3 WuXi ATU Oncolytic Virus Manufacturing and Development Services Introduction

11.14.4 WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.14.5 WuXi ATU Recent Development

11.15 Genevoyager

11.15.1 Genevoyager Company Details

11.15.2 Genevoyager Business Overview

11.15.3 Genevoyager Oncolytic Virus Manufacturing and Development Services Introduction

11.15.4 Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

11.15.5 Genevoyager Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Recipharm (Vibalogics)

Idt Biologika

FUJIFILM Diosynth Biotechnologies

Exothera

Lonza

Creative-Biolabs

Takara Bio

Libentech

ABL, Inc.

Nabios

HALIX

OBiO Technology

Porton Advanced

WuXi ATU

Genevoyager

List of Tables

Table 1. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oncolytic Herpes Simplex Virus

Table 3. Key Players of Oncolytic Adenovirus

Table 4. Key Players of Oncolytic Vaccinia Virus

Table 5. Key Players of Others

Table 6. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026

Table 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2026)

Table 10. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2027–2032)

Table 12. Oncolytic Virus Manufacturing and Development Services Market Trends

Table 13. Oncolytic Virus Manufacturing and Development Services Market Drivers

Table 14. Oncolytic Virus Manufacturing and Development Services Market Challenges

Table 15. Oncolytic Virus Manufacturing and Development Services Market Restraints

Table 16. Global Oncolytic Virus Manufacturing and Development Services Revenue by Players (US$ Million), 2021–2026

Table 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players (2021–2026)

Table 18. Global Top Oncolytic Virus Manufacturing and Development Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncolytic Virus Manufacturing and Development Services Revenue, 2025

Table 19. Ranking of Global Top Oncolytic Virus Manufacturing and Development Services Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Headquarters and Area Served

Table 22. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications

Table 23. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Oncolytic Virus Manufacturing and Development Services Market Size by Type (US$ Million), 2021–2026

Table 26. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2021–2026)

Table 27. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2027–2032)

Table 29. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2026

Table 30. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2021–2026)

Table 31. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2027–2032)

Table 33. North America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026

Table 35. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032

Table 48. Recipharm (Vibalogics) Company Details

Table 49. Recipharm (Vibalogics) Business Overview

Table 50. Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product

Table 51. Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 52. Recipharm (Vibalogics) Recent Development

Table 53. IDT Biologika Company Details

Table 54. IDT Biologika Business Overview

Table 55. IDT Biologika Oncolytic Virus Manufacturing and Development Services Product

Table 56. IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 57. IDT Biologika Recent Development

Table 58. FUJIFILM Diosynth Biotechnologies Company Details

Table 59. FUJIFILM Diosynth Biotechnologies Business Overview

Table 60. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product

Table 61. FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 62. FUJIFILM Diosynth Biotechnologies Recent Development

Table 63. Exothera Company Details

Table 64. Exothera Business Overview

Table 65. Exothera Oncolytic Virus Manufacturing and Development Services Product

Table 66. Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 67. Exothera Recent Development

Table 68. Lonza Company Details

Table 69. Lonza Business Overview

Table 70. Lonza Oncolytic Virus Manufacturing and Development Services Product

Table 71. Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 72. Lonza Recent Development

Table 73. Creative Biolabs Company Details

Table 74. Creative Biolabs Business Overview

Table 75. Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product

Table 76. Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 77. Creative Biolabs Recent Development

Table 78. Takara Bio Company Details

Table 79. Takara Bio Business Overview

Table 80. Takara Bio Oncolytic Virus Manufacturing and Development Services Product

Table 81. Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 82. Takara Bio Recent Development

Table 83. Libentech Company Details

Table 84. Libentech Business Overview

Table 85. Libentech Oncolytic Virus Manufacturing and Development Services Product

Table 86. Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 87. Libentech Recent Development

Table 88. ABL Company Details

Table 89. ABL Business Overview

Table 90. ABL Oncolytic Virus Manufacturing and Development Services Product

Table 91. ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 92. ABL Recent Development

Table 93. Nabios Company Details

Table 94. Nabios Business Overview

Table 95. Nabios Oncolytic Virus Manufacturing and Development Services Product

Table 96. Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 97. Nabios Recent Development

Table 98. Halix Company Details

Table 99. Halix Business Overview

Table 100. Halix Oncolytic Virus Manufacturing and Development Services Product

Table 101. Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 102. Halix Recent Development

Table 103. Obio Technology Company Details

Table 104. Obio Technology Business Overview

Table 105. Obio Technology Oncolytic Virus Manufacturing and Development Services Product

Table 106. Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 107. Obio Technology Recent Development

Table 108. Porton Advanced Company Details

Table 109. Porton Advanced Business Overview

Table 110. Porton Advanced Oncolytic Virus Manufacturing and Development Services Product

Table 111. Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 112. Porton Advanced Recent Development

Table 113. WuXi ATU Company Details

Table 114. WuXi ATU Business Overview

Table 115. WuXi ATU Oncolytic Virus Manufacturing and Development Services Product

Table 116. WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 117. WuXi ATU Recent Development

Table 118. Genevoyager Company Details

Table 119. Genevoyager Business Overview

Table 120. Genevoyager Oncolytic Virus Manufacturing and Development Services Product

Table 121. Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026

Table 122. Genevoyager Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Oncolytic Virus Manufacturing and Development Services Picture

Figure 2. Global Oncolytic Virus Manufacturing and Development Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Oncolytic Virus Manufacturing and Development Services Market Share by Type: 2025 vs 2032

Figure 4. Oncolytic Herpes Simplex Virus Features

Figure 5. Oncolytic Adenovirus Features

Figure 6. Oncolytic Vaccinia Virus Features

Figure 7. Others Features

Figure 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Application: 2025 vs 2032

Figure 10. R&D Case Studies

Figure 11. Biopharmaceutical Manufacturers Case Studies

Figure 12. Others Case Studies

Figure 13. Oncolytic Virus Manufacturing and Development Services Report Years Considered

Figure 14. Global Oncolytic Virus Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Oncolytic Virus Manufacturing and Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region: 2025 vs 2032

Figure 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players in 2025

Figure 18. Global Oncolytic Virus Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue in 2025

Figure 20. North America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)

Figure 22. United States Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)

Figure 26. Germany Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2032)

Figure 34. China Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)

Figure 42. Mexico Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)

Figure 46. Israel Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Recipharm (Vibalogics) Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 50. IDT Biologika Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 52. Exothera Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 53. Lonza Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 54. Creative Biolabs Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 55. Takara Bio Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 56. Libentech Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 57. ABL Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 58. Nabios Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 59. Halix Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 60. Obio Technology Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 61. Porton Advanced Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 62. WuXi ATU Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 63. Genevoyager Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Development and Manufacturing Services Market Research Report 2025

Global Oncolytic Virus Market Insights Forecast to 2030

Global Oncolytic Virus Therapy Market Research Report 2025

Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

Global Oncolytic Viral Drugs Market Research Report 2024

Global Oncolytic Virus Immunotherapy Market Research Report 2024

Global Nanomedicine Development and Manufacturing Services Market Research Report 2025

Global mRNA Development and Manufacturing Services Market Research Report 2025

Global Research Grade Viral Vector Packaging Service Market Research Report 2025

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

Global Vaccine Development Service Market Research Report 2025

Global Viral Vector Manufacturing Services Market Research Report 2024

Viral Vector Packaging Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Clearance Service Market Insights Forecast to 2030

Global Immuno Oncology Service Market Research Report 2024

Global Adenovirus Services Market Research Report 2025

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions